JP2022514537A - 急性心房細動の処置のためのサルカルディン投与 - Google Patents

急性心房細動の処置のためのサルカルディン投与 Download PDF

Info

Publication number
JP2022514537A
JP2022514537A JP2021534215A JP2021534215A JP2022514537A JP 2022514537 A JP2022514537 A JP 2022514537A JP 2021534215 A JP2021534215 A JP 2021534215A JP 2021534215 A JP2021534215 A JP 2021534215A JP 2022514537 A JP2022514537 A JP 2022514537A
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
pharmaceutical composition
sarcardin
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021534215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514537A5 (https=
Inventor
ロマーノ，スザンヌ，ジェイ．
エリオット，ゲイリー，ティー．
Original Assignee
フヤ バイオサイエンス インターナショナル エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フヤ バイオサイエンス インターナショナル エルエルシー filed Critical フヤ バイオサイエンス インターナショナル エルエルシー
Publication of JP2022514537A publication Critical patent/JP2022514537A/ja
Publication of JP2022514537A5 publication Critical patent/JP2022514537A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021534215A 2018-12-13 2019-12-12 急性心房細動の処置のためのサルカルディン投与 Pending JP2022514537A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862779056P 2018-12-13 2018-12-13
US62/779,056 2018-12-13
US201962858324P 2019-06-06 2019-06-06
US62/858,324 2019-06-06
PCT/US2019/066003 WO2020123824A1 (en) 2018-12-13 2019-12-12 Sulcardine administration for treatment of acute atrial fibrillation

Publications (2)

Publication Number Publication Date
JP2022514537A true JP2022514537A (ja) 2022-02-14
JP2022514537A5 JP2022514537A5 (https=) 2022-12-19

Family

ID=69165588

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021534215A Pending JP2022514537A (ja) 2018-12-13 2019-12-12 急性心房細動の処置のためのサルカルディン投与

Country Status (11)

Country Link
US (4) US11364223B2 (https=)
EP (1) EP3893870A1 (https=)
JP (1) JP2022514537A (https=)
KR (1) KR20210135990A (https=)
CN (1) CN113453677A (https=)
AU (1) AU2019397511B2 (https=)
CA (1) CA3123078A1 (https=)
IL (1) IL283931A (https=)
MX (1) MX2021006933A (https=)
WO (1) WO2020123824A1 (https=)
ZA (1) ZA202104166B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023529196A (ja) * 2020-06-12 2023-07-07 フヤバイオ インターナショナル，エルエルシー 急性心房細動の治療のためのサルカルディン投与

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113453677A (zh) 2018-12-13 2021-09-28 沪亚生物国际有限责任公司 用于治疗急性心房颤动的舒卡定施用
SG11202108160YA (en) 2019-01-29 2021-08-30 Huya Bioscience International Llc Sulcardine salts
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011062906A2 (en) * 2009-11-17 2011-05-26 Elliot Gary T Treatment of atrial fibrillation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
JP5308333B2 (ja) 2006-06-30 2013-10-09 シグマ−タウ レア ディジージズ エスィアー Ｌ−アスパラギナーゼｉｉを産生する組換え宿主
EP2468869B1 (en) 2007-01-31 2015-03-18 Pfenex Inc. Bacterial leader sequences for increased expression
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts
KR20130072201A (ko) 2010-03-30 2013-07-01 피페넥스 인크. 재조합 독소 단백질의 고수준 발현
KR102092225B1 (ko) 2014-04-30 2020-03-23 주식회사 엘지화학 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터
CN107532190B (zh) 2014-12-01 2021-07-09 菲尼克斯公司 用于肽生产的融合伴侣
AU2016272089B2 (en) 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
AU2017261372B2 (en) 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
EP3573602A4 (en) 2017-01-26 2020-09-16 Triastek, Inc. DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
CN113453677A (zh) 2018-12-13 2021-09-28 沪亚生物国际有限责任公司 用于治疗急性心房颤动的舒卡定施用
SG11202108160YA (en) 2019-01-29 2021-08-30 Huya Bioscience International Llc Sulcardine salts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011062906A2 (en) * 2009-11-17 2011-05-26 Elliot Gary T Treatment of atrial fibrillation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023529196A (ja) * 2020-06-12 2023-07-07 フヤバイオ インターナショナル，エルエルシー 急性心房細動の治療のためのサルカルディン投与

Also Published As

Publication number Publication date
IL283931A (en) 2021-07-29
AU2019397511A1 (en) 2021-07-22
MX2021006933A (es) 2021-09-30
US20250302805A1 (en) 2025-10-02
US20240115548A1 (en) 2024-04-11
US12357611B2 (en) 2025-07-15
WO2020123824A1 (en) 2020-06-18
AU2019397511B2 (en) 2025-08-21
CN113453677A (zh) 2021-09-28
US20200188357A1 (en) 2020-06-18
CA3123078A1 (en) 2020-06-18
US11883380B2 (en) 2024-01-30
EP3893870A1 (en) 2021-10-20
US20220280480A1 (en) 2022-09-08
US11364223B2 (en) 2022-06-21
ZA202104166B (en) 2023-11-29
KR20210135990A (ko) 2021-11-16

Similar Documents

Publication Publication Date Title
JP2022514537A (ja) 急性心房細動の処置のためのサルカルディン投与
US20110166220A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
JP6116908B2 (ja) 心房細動の治療
JP2013511473A5 (https=)
US20110166221A1 (en) Use of dronedarone for the preparation of a medicament for use in the prevention of cardioversion
JP2013511472A (ja) サルカルディン及びその塩の緩速点滴
US12465587B2 (en) Sulcardine administration for treatment of acute atrial fibrillation
JP2018537522A (ja) 組合せ
EA045624B1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий
WO2026046312A1 (zh) 一种用于预防或治疗纤维化疾病的药物
HK40061591A (en) Sulcardine administration for treatment of acute atrial fibrillation
JP6935930B2 (ja) 生薬成分を含む肺高血圧症の予防又は治療剤
KR20040083498A (ko) 심부전증 및 기타 노화-관련된 기관의 기능장애,노화-관련 질환을 예방하고 생명을 연장하기 위한 ａｃｅ억제제와 나트륨-수소 교환 억제제 카리포리드와의 배합제제
TW201200131A (en) Use of dronedarone for the preparation of a medicament for the prevention of cardiovacular hospitalizations or death or cardiovascular events in patients with premanent atrial fibrillation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221209

RD12 Notification of acceptance of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7432

Effective date: 20230111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230111

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240214

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240422